Johnson & Johnson subsidiary Janssen Pharmaceuticals has settled 76 cases in which plaintiffs alleged that the anti-seizure drug Topamax, taken during pregnancy, caused birth defects, according to a Philadelphia court order.

Philadelphia Court of Common Pleas Judge Arnold New, coordinating judge of the court’s Complex Litigation Center, ordered that the affected cases be marked as “discontinued” and removed from the mass tort inventory.